Mod­er­na takes one more step along the high-wire act of Covid-19 vac­cine work, of­fer­ing mark­ers of suc­cess for the most vul­ner­a­ble age group

One of the big ques­tions fac­ing any of the Covid-19 vac­cines is whether or not they can pro­tect the el­der­ly — the most vul­ner­a­ble group fac­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.